. 2019 Dec 31;14(12):e0227266. doi: 10.1371/journal.pone.0227266

Table 1. LCN2 levels of patients and controls.

	LCN2 levels							P-value	P-value after sensitivity analysis
	Mean	Standard deviation	Median	Minimum value	Maximum Value	Interquartile range	N	P-value	P-value after sensitivity analysis
Controls	2,975	1,634	3,289	200	4,803	3,090	10	<0.001^a	0.001^a
RRD (total)	23,481	52,926	7,095	2,311	259,625	9,605	24
Lens status								0.007^a	0.082^a
Phakic	5,824	2,720	4,879	2,311	10,527	4,550	12
Pseudophakic	41,137	71,899	13,124	2,520	259,625	40,014	12
PVR grading								<0.001^b	<0.001^b
No PVR	3,779	1,209	3,921	2,311	5,561	2,132	7
PVR A	5,084	358	4,916	4,541	5,495	Non computable	3
PVR B	8,609	1,879	9,387	6,055	10,763	3,721	7
PVR C	65,938	88,032	35,759	10,527	259,625	55,346	7
Quadrants								<0.001^a	<0.001^a
1–2	3,779	1,209	3,921	2,311	5,561	2,132	7
3–4	31,593	61,534	10,005	4841	259,625	21,316	17
Symptoms duration (days)								<0.001^b	<0.001^b
<10	4,023	1,155	4,479	2,311	5,561	2,113	9
11–30	15,580	19,802	9625	5495	70,883	6,649	10
>30	74,304	104,81	35,759	10,527	259,625	141,867	5

^a Mann-Whitney

^b Spearman’s correlation coefficient